BIO-TECHNE CORP holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 990,099 | $58,049,504 | 0.16% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 972,085 | $50,013,773 | 0.13% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 29, 2025 |
| Sept. 30, 2025 | 1,709,662 | $95,108,497 | 0.25% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 2,398,265 | $141,041,965 | 0.39% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 9, 2026 |
| March 31, 2026 | 2,462,487 | $128,689,571 | 0.43% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 8, 2026 |
| June 30, 2026 | 4,060 | $286,839 | 0.00% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.